🔎 Trials Near Me

Akèy › Kansè kanal bil (Kolangyokasinòm)

Etid klinik pou Kansè kanal bil (Kolangyokasinòm) ap rekrite nan Etazini

56 etid pou Kansè kanal bil (Kolangyokasinòm) ap rekrite patisipan nan sit atravè Etazini.

Vil ki gen plis etid

Pa eta

Etid ki fèk mete ajou

Tèks ofisyèl etid la (Anglè)

Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer

Ap rekriteEtid obsèvasyon
Laj 2 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT01915225

A Study of PHST001 in Advanced Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT06840886

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06270706

Evaluating Efficacy of Tivozanib (AV-951) in Biliary Tract Cancers

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04645160

Pemigatinib + Afatinib in Advanced Refractory Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06302621

Trifluridine/Tipiracil + Oxaliplatin in Participants With Advanced or Metastatic Biliary Tract Cancer

Ap rekriteFaz 2
Laj 19 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07146646

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07213791

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07488676

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma

Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07780838

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT05732831

Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers

Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Aug 31, 2026 · NCT05497531

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT07486713

TCR1188-ABC Cells in KRAS-mutated Cancers

Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT07594067

D07001 Softgel-Capsules and Capecitabine Combination Therapy in Patients With Advanced Biliary Tract Cancer

Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT06622057

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.